Literature DB >> 19542217

Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Gopal Sapparapu1, Stephanie A Planque, Yasuhiro Nishiyama, Steven K Foung, Sudhir Paul.   

Abstract

The antigen recognition site of antibodies consists of the heavy and light chain variable domains (V(L) and V(H) domains). V(L) domains catalyze peptide bond hydrolysis independent of V(H) domains (Mei, S., Mody, B., Eklund, S. H., and Paul, S. (1991) J. Biol. Chem. 266, 15571-15574). V(H) domains bind antigens noncovalently independent of V(L) domains (Ward, E. S., Güssow, D., Griffiths, A. D., Jones, P. T., and Winter, G. (1989) Nature 341, 544-546). We describe specific hydrolysis of fusion proteins of the hepatitis C virus E2 protein with glutathione S-transferase (GST-E2) or FLAG peptide (FLAG-E2) by antibodies containing the V(H) domain of an anti-E2 IgG paired with promiscuously catalytic V(L) domains. The hybrid IgG hydrolyzed the E2 fusion proteins more rapidly than the unpaired light chain. An active site-directed inhibitor of serine proteases inhibited the proteolytic activity of the hybrid IgG, indicating a serine protease mechanism. The hybrid IgG displayed noncovalent E2 binding in enzyme-linked immunosorbent assay tests. Immunoblotting studies suggested hydrolysis of FLAG-E2 at a bond within E2 located approximately 11 kDa from the N terminus. GST-E2 was hydrolyzed by the hybrid IgG at bonds in the GST tag. The differing cleavage pattern of FLAG-E2 and GST-E2 can be explained by the split-site model of catalysis, in which conformational differences in the E2 fusion protein substrates position alternate peptide bonds in register with the antibody catalytic subsite despite a common noncovalent binding mechanism. These studies provide proof-of-principle that the catalytic activity of a light chain can be rendered antigen-specific by pairing with a noncovalently binding heavy chain subunit.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542217      PMCID: PMC2782051          DOI: 10.1074/jbc.M109.011858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  Biogenesis of hepatitis C virus envelope glycoproteins.

Authors:  Anne Op De Beeck; Laurence Cocquerel; Jean Dubuisson
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

Review 2.  Protein blotting: a review.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

Review 3.  The chemistry of the antibody molecule.

Authors:  Peter G Schultz; Jun Yin; Richard A Lerner
Journal:  Angew Chem Int Ed Engl       Date:  2002-12-02       Impact factor: 15.336

4.  Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120.

Authors:  S Karle; Y Nishiyama; H Taguchi; Y-X Zhou; J Luo; S Planque; C Hanson; S Paul
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

5.  Phosphonate ester probes for proteolytic antibodies.

Authors:  S Paul; A Tramontano; G Gololobov; Y X Zhou; H Taguchi; S Karle; Y Nishiyama; S Planque; S George
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

6.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Jin-Quan Luo; Yong-Xin Zhou; Gary Burr; Sangeeta Karle; Sudhir Paul
Journal:  Arch Biochem Biophys       Date:  2002-06-15       Impact factor: 4.013

8.  Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

Authors:  RosaMaria Roccasecca; Helenia Ansuini; Alessandra Vitelli; Annalisa Meola; Elisa Scarselli; Stefano Acali; Monica Pezzanera; Bruno Bruni Ercole; Jane McKeating; Asutosh Yagnik; Armin Lahm; Anna Tramontano; Riccardo Cortese; Alfredo Nicosia
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Degradation of beta-amyloid by proteolytic antibody light chains.

Authors:  Srinath Kasturi Rangan; Ruitian Liu; Daniel Brune; Stephanie Planque; Sudhir Paul; Michael R Sierks
Journal:  Biochemistry       Date:  2003-12-09       Impact factor: 3.162

10.  Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.

Authors:  R S Russell; K Kawaguchi; J-C Meunier; S Takikawa; K Faulk; J Bukh; R H Purcell; S U Emerson
Journal:  J Viral Hepat       Date:  2009-03-11       Impact factor: 3.728

View more
  7 in total

1.  Specific amyloid β clearance by a catalytic antibody construct.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Sari Sonoda; Yan Lin; Hiroaki Taguchi; Mariko Hara; Steven Kolodziej; Yukie Mitsuda; Veronica Gonzalez; Hameetha B R Sait; Ken-ichiro Fukuchi; Richard J Massey; Robert P Friedland; Brian O'Nuallain; Einar M Sigurdsson; Sudhir Paul
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

2.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

3.  IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes.

Authors:  Alfreda D Nelson; Michele M Hoffmann; Christopher A Parks; Surendra Dasari; Adam G Schrum; Diana Gil
Journal:  J Biol Chem       Date:  2012-10-29       Impact factor: 5.157

Review 4.  Back to the future: covalent epitope-based HIV vaccine development.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama; Miguel Escobar; Carl Hanson
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

5.  Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein.

Authors:  Daria A Kamaeva; Liudmila P Smirnova; Svetlana N Vasilieva; Daria V Kazantseva; Alisa R Vasilieva; Svetlana A Ivanova
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

6.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

7.  Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia.

Authors:  Daria A Parshukova; Liudmila P Smirnova; Elena G Kornetova; Arkadiy V Semke; Valentina N Buneva; Svetlana A Ivanova
Journal:  J Immunol Res       Date:  2020-08-10       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.